| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.8 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.8 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.017 | 0.8 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |